keyword
Keywords Neutrophil lymphocytic ratio i...

Neutrophil lymphocytic ratio in cancer

https://read.qxmd.com/read/38645565/microenvironment-systemic-inflammatory-response-and-tumor-markers-considering-consensus-molecular-subtypes-of-colorectal-cancer
#1
JOURNAL ARTICLE
Anna Jakab, Árpád V Patai, Mónika Darvas, Karolina Tormássi-Bély, Tamás Micsik
Introduction: Colorectal carcinomas (CRC) are one of the most frequent malignancies worldwide. Based on gene expression profile analysis, CRCs can be classified into four distinct subtypes also known as the consensus molecular subtypes (CMS), which predict biological behaviour. Besides CMS, several other aspects of tumor microenvironment (TME) and systemic inflammatory response (SIR) influence the outcome of CRC patients. TME and inflammation have important role in the immune (CMS1) and mesenchymal (CMS4) subtypes, however, the relationship between these and systemic inflammation has not been assessed yet...
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38645410/association-between-monocyte-to-lymphocyte-ratio-and-prostate-cancer-in-the-u-s-population-a-population-based-study
#2
JOURNAL ARTICLE
Lanyu Wang, Xiaowan Li, Min Liu, Hongyi Zhou, Jianfeng Shao
INTRODUCTION: Monocyte-to-lymphocyte ratio (MLR) is a convenient and noninvasive inflammatory biomarker, and inflammation has been reported to be associated with prostate cancer (PCa). Our objective was to ascertain any possible correlation between PCa and MLR. METHODS: We utilized data from the 1999-2020 cycles of the National Health and Nutrition Examination Survey (NHANES) regarding MLR and PCa. The independent associations of MLR and other inflammatory biomarkers (platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), system inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)) with PCa was investigated using weighted multivariate logistic regression and generalized additive models...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38641451/develop-and-validate-a-nomogram-combining-contrast-enhanced-spectral-mammography-deep-learning-with-clinical-pathological-features-to-predict-neoadjuvant-chemotherapy-response-in-patients-with-er-positive-her2-negative-breast-cancer
#3
JOURNAL ARTICLE
Dong Xing, Yongbin Lv, Bolin Sun, Tongpeng Chu, Qianhao Bao, Han Zhang
RATIONALE AND OBJECTIVES: To develop and validate a nomogram that combines contrast-enhanced spectral mammography (CESM) deep learning with clinical-pathological features to predict neoadjuvant chemotherapy (NAC) response (either low Miller Payne (MP-L) grades 1-2 or high MP (MP-H) grades 3-5) in patients with ER-positive/HER2-negative breast cancer. MATERIALS AND METHODS: In this retrospective study, 265 breast cancer patients were randomly allocated into training and test sets (used for models training and testing, respectively) at a 4:1 ratio...
April 18, 2024: Academic Radiology
https://read.qxmd.com/read/38638242/assessing-the-effectiveness-and-safety-of-lenvatinib-and-everolimus-in-advanced-renal-cell-carcinoma-insights-from-the-relieve-study-s-analysis-of-heavily-pretreated-patients
#4
JOURNAL ARTICLE
Sebastiano Buti, Alessandro Olivari, Cristina Masini, Davide Bimbatti, Donata Sartori, Paola Ermacora, Carlo Cattrini, Maria Giuseppa Vitale, Ernesto Rossi, Claudia Mucciarini, Mimma Rizzo, Michele Sisani, Matteo Santoni, Giandomenico Roviello, Veronica Mollica, Vincenza Conteduca, Francesco Grillone, Marika Cinausero, Giuseppe Prati, Francesco Atzori, Marco Stellato, Francesco Massari, Melissa Bersanelli
BACKGROUND: The treatment of heavily pretreated patients with metastatic renal cell carcinoma (mRCC) represents an unmet medical need and is still challenging. OBJECTIVES: The primary objective was to assess the effectiveness of the lenvatinib plus everolimus combination and the secondary objective was the toxicity profile of this combination. DESIGN: We conducted a longitudinal retrospective study examining mRCC patients pre-treated with one or more lines of therapy among different cancer centers in Italy...
2024: Therapeutic Advances in Urology
https://read.qxmd.com/read/38636630/preoperative-blood-counts-predict-overall-survival-in-patients-undergoing-surgical-removal-of-brain-metastasis
#5
JOURNAL ARTICLE
Ryosuke Matsuda, Ryosuke Maeoka, Takayuki Morimoto, Tsutomu Nakazawa, Yudai Morisaki, Kenta Nakase, Shohei Yokoyama, Masashi Kotsugi, Yasuhiro Takeshima, Shuichi Yamada, Ichiro Nakagawa
OBJECTIVE: The prognosis for patients with cancer with brain metastasis (BM) requiring surgical removal is quite limited. Preoperative prognostic factors can provide meaningful information to surgeons, oncologists, and patients. This study evaluated the preoperative blood counts in patients with BM who were treated with surgical removal. METHODS: Between January 2011 and November 2021, 221 consecutive surgeries were conducted on 198 patients with BM. Among the 198 patients, 188 patients with sufficient blood test data and follow-up were analyzed in this study...
April 16, 2024: World Neurosurgery
https://read.qxmd.com/read/38636361/systemic-immune-inflammation-index-is-associated-with-cardiac-complications-following-acute-ischemic-stroke-a-retrospective-single-center-study
#6
JOURNAL ARTICLE
Xiaodi Hao, Mingfang Zhu, Zhengyu Sun, Penghui Li, Qi Meng, Leilei Tan, Chen Chen, Yakun Zhang, Lihua Yang, Jiewen Zhang, Yue Huang
BACKGROUND: Stroke-induced heart syndrome is a feared complication of ischemic stroke, that is commonly encountered and has a strong association with unfavorable prognosis. More research is needed to explore underlying mechanisms and inform clinical decision making. This study aims to explore the relationship between the early systemic immune-inflammation (SII) index and the cardiac complications after acute ischemic stroke. METHODS: Consecutive patients with acute ischemic stroke were prospectively collected from January 2020 to August 2022 and retrospectively analyzed...
April 12, 2024: Clinical Neurology and Neurosurgery
https://read.qxmd.com/read/38627776/the-value-of-lung-function-assessment-and-testin-expression-detection-in-clinicopathological-features-and-prognosis-of-nsclc-patients
#7
JOURNAL ARTICLE
Yanmin Zhang, Gaoming Wang, Qian Zhang, Qian Wang, Jing Luo, Chunhua Ling
OBJECTIVE: The aim of this study is to investigate the clinical value and potential prognostic significance of lung function assessment and Testin expression in non-small cell lung cancer (NSCLC) patients. METHODS: The NSCLC patients were classified into three groups according to lung function: group of normal lung function, group of PRISm (preserved ratio impaired spirometry) (FEV1, forced expiratory volume during the first second < 80% predicted and FEV1/FVC (forced vital capacity) ≥ 70%) and group of COPD (chronic obstructive pulmonary disease) (FEV1/FVC < 70%)...
April 16, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38627156/neutrophil-to-lymphocyte-ratio-and-risk-of-nodal-metastasis-in-early-stage-lung-adenocarcinoma-a-brief-report-from-a-multicentric-analysis
#8
Filippo Tommaso Gallina, Marco Chiappetta, Riccardo Tajè, Daniele Forcella, Carolina Sassorossi, Maria Teresa Congedo, Jessica Evangelista, Isabella Sperduti, Filippo Lococo, Federico Cappuzzo, Enrico Melis, Stefano Margaritora, Francesco Facciolo
No abstract text is available yet for this article.
March 15, 2024: Clinical Lung Cancer
https://read.qxmd.com/read/38626660/adrenocortical-cancer-in-the-real-world-a-comprehensive-analysis-of-clinical-features-and-management-from-the-turkish-oncology-group-tog
#9
JOURNAL ARTICLE
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, Sema Sezgin Goksu, Irem Bilgetekin, Burcu Cakar, Abdullah Sakin, Ozturk Ates, Tugba Basoglu, Cagatay Arslan, Atike Gokcen Demiray, Semra Paydas, Irfan Cicin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Hakan Kosku, Aytuğ Uner, Perran Fulden Yumuk, Gungor Utkan, Umut Kefeli, Ozgur Tanriverdi, Havva Cinkir, Ozge Gumusay, Nazım Serdal Turhal, Serkan Menekse, Engin Kut, Ismail Beypinar, Teoman Sakalar, Hacer Demir, Emre Yekeduz, Saadettin Kilickap, Mustafa Erman, Yuksel Urun
INTRODUCTION: Adrenocortical carcinoma (ACC) is a rare yet highly malignant tumor associated with significant morbidity and mortality. This study aims to delineate the clinical features, survival patterns, and treatment modalities of ACC, providing insights into the disease's prognosis. MATERIALS AND METHODS: A retrospective analysis of 157 ACC patients was performed to assess treatment methodologies, demographic patterns, pathological and clinical attributes, and laboratory results...
March 15, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38625663/systemic-inflammation-score-as-a-predictor-of-death-within-one-year-after-esophagectomy
#10
JOURNAL ARTICLE
Shinsuke Sato, Eiji Nakatani, Philip Hawke, Erina Nagai, Yusuke Taki, Masato Nishida, Masaya Watanabe, Ko Ohata, Hideyuki Kanemoto, Noriyuki Oba
BACKGROUND: After radical resection for esophageal cancer, death within 1 year of surgery can occur due both to recurrence and to other diseases, even after postoperative complications have been overcome. This study identified risk factors for early death within 1 year of esophagectomy for reasons other than death in hospital in patients undergoing esophagectomy for esophageal cancer or esophagogastric junction cancer. METHODS: We reviewed 366 patients who underwent esophagectomy without adjuvant treatment between January 2009 and July 2022 for thoracic esophageal cancer or esophagogastric junction cancer...
April 16, 2024: Esophagus: Official Journal of the Japan Esophageal Society
https://read.qxmd.com/read/38623101/salivary-neutrophil-to-lymphocyte-ratio-as-a-prognostic-predictor-of-oral-premalignant-and-malignant-disorders-a-prospective-study
#11
JOURNAL ARTICLE
Dilip B Magdum, Noopur A Kulkarni, Pratibha G Kavle, Swati Paraye, Pritam S Pohankar, Amol V Giram
INTRODUCTION: Inflammation is a definitive characteristic of carcinogenesis. The neutrophil-to-lymphocyte ratio (NLR) is an easy and efficient indicator of inflammation and a valuable marker in individuals with malignancies. The present study was performed to ascertain NLR values in salivary samples collected from individuals with oral premalignant disorders (OPMDs) and to assess the prognostic significance of NLR in distinguishing OPMDs from oral malignancies. MATERIALS AND METHODS: This study was conducted on 50 patients histopathologically diagnosed with OPMDs with mild dysplasia...
March 2024: Curēus
https://read.qxmd.com/read/38617514/nomograms-for-predicting-prognostic-value-of-combined-neutrophil-to-lymphocyte-ratio-and-scc-ag-in-locally-advanced-cervical-cancer
#12
JOURNAL ARTICLE
Long Jin, Fei Cao, Yuan Zhang, Yunzhi Dang, Fei Wang
BACKGROUND: Accumulating evidence supports the important role of inflammation in tumorigenesis and progression. Squamous cell carcinoma-associated antigen (SCC-Ag) is a tumor marker widely used to predict the prognosis of patients with cervical squamous cell carcinoma. This paper explored the predictive value of combined detection of neutrophil-to-lymphocyte ratio (NLR) to SCC-Ag for prognosis in patients with locally advanced cervical cancer (LACC). METHODS: A retrospective analysis was conducted on 190 LACC patients who underwent concurrent chemoradiotherapy (CCRT) from January 2012 to December 2016...
March 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38617385/effect-of-intraoperative-opioid-dose-on-perioperative-neutrophil-to-lymphocyte-ratio-and-lymphocyte-to-monocyte-ratio-in-glioma
#13
JOURNAL ARTICLE
Xuejiao Liu, Lei Teng, Junzhu Dai, Hongxue Shao, Rui Chen, Haixiang Li, Jing Li, Huichao Zou
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are inflammatory biomarkers. Until now, it is unknown the impact of opioid dosage on perioperative immunity in glioma patients. The aim of this study was to explore the effect of intraoperative opioid dosage on perioperative immune perturbations using NLR and LMR as inflammatory biomarkers and evaluate the correlation between inflammatory biomarkers and pathological grade of glioma. METHODS: The study included 208 patients with primary glioma who underwent glioma resection from February 2012 to November 2019 at Harbin Medical University Cancer Hospital...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38616289/the-prognostic-role-of-pre-treatment-neutrophil-to-lymphocyte-ratio-and-platelet-to-lymphocyte-ratio-in-esophageal-squamous-cell-carcinoma-treated-with-concurrent-chemoradiotherapy
#14
JOURNAL ARTICLE
Qirong Man, Peishun Li, Jing Fan, Sen Yang, Chao Xing, Yunling Bai, Miaomiao Hu, Baohu Wang, Kaixian Zhang
PURPOSE: In this study, we retrospectively investigated the prognostic role of pre-treatment neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in esophageal squamous cell carcinoma patients (ESCC) treated with concurrent chemo-radiotherapy (CCRT). METHODS: We retrospectively analyzed the records of 338 patients with pathologically diagnosed esophageal squamous cell carcinoma that underwent concurrent chemo-radiotherapy from January 2013 to December 2017...
April 15, 2024: BMC Cancer
https://read.qxmd.com/read/38615487/nlr-outperforms-low-hemoglobin-and-high-platelet-count-as-predictive-and-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-treated-with-immune-checkpoint-inhibitors
#15
JOURNAL ARTICLE
Matthew Young, Jose C Tapia, Bernadett Szabados, Agne Jovaisaite, Francesca Jackson-Spence, Elizabeth Nally, Thomas Powles
BACKGROUND: Reliable biomarkers in renal cell carcinoma (RCC) remain elusive. While several markers have been shown to be associated with prognosis, and may aid in risk assessment, predictive biomarkers of response to immune checkpoint inhibitors (ICIs) have not been established. Previous studies have shown that a high pretreatment neutrophil-lymphocyte ratio (NLR) is a negative prognostic factor in RCC. However, a clinically useful cut-off for the predictive and prognostic value of NLR has not been well defined...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38614212/preoperative-exercise-training-decreases-complications-of-minimally-invasive-lung-cancer-surgery-a-randomized-controlled-trial
#16
JOURNAL ARTICLE
Nanjiang Zhou, Jeffrey W Ripley-Gonzalez, Wenliang Zhang, Kangling Xie, Baiyang You, Yanan Shen, Zeng Cao, Ling Qiu, Cui Li, Siqian Fu, Chunfang Zhang, Yaoshan Dun, Yang Gao, Suixin Liu
OBJECTIVE: Limited evidence exists regarding the efficacy of preoperative exercise (PE) in reducing short-term complications after minimally invasive surgery in patients with non-small cell lung cancer (NSCLC). This study aims to investigate the impact of PE on short-term complications following minimally invasive lung resection. METHODS: In this prospective, open-label, randomized (1:1) controlled trial at Xiangya Hospital, China (Sep 2020-Feb 2022), patients were randomly assigned to a PE group with 16-day alternate supervised exercise or a control...
April 11, 2024: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38613344/predictive-value-of-nlr-and-plr-in-driver-gene-negative-advanced-non-small-cell-lung-cancer-treated-with-pd-1-pd-l1-inhibitors-a-single-institutional-cohort-study
#17
JOURNAL ARTICLE
Qi Yuan, Chunhua Xu, Wei Wang, Qian Zhang
OBJECTIVE: To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for the efficacy and prognosis of programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors in driver-gene-negative advanced non-small-cell lung cancer (NSCLC). METHODS: A retrospective analysis of 107 advanced NSCLC patients without gene mutations who received PD-1/PD-L1 inhibitors in our hospital from January 2020 to June 2022 was performed...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38613258/prognostic-impact-of-muscle-mass-loss-in-elderly-patients-with-oesophageal-cancer-receiving-neoadjuvant-chemoradiation-therapy
#18
JOURNAL ARTICLE
Jeong Yun Jang, Dongryul Oh, Jae Myoung Noh, Jong-Mu Sun, Hong Kwan Kim, Young Mog Shim
BACKGROUND: We aimed to identify the impact of muscle mass on locally advanced oesophageal cancer (LAEC) in elderly patients receiving neoadjuvant chemoradiation therapy (NACRT). METHODS: We reviewed the medical records of 345 patients diagnosed with LAEC who underwent NACRT and surgery. Physical variables, including height, weight, skeletal muscle mass, and laboratory values, were obtained before and after NACRT. Body mass index (BMI, kg/m2 ), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) were calculated as height/(weight)2 , ANC/ALC, platelet count/ALC, and (10 × albumin + 0...
April 13, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38610718/prognostic-value-of-postneoadjuvant-chemotherapy-neutrophil-to-lymphocyte-ratio-in-patients-undergoing-radical-cystectomy
#19
JOURNAL ARTICLE
Krystian Kaczmarek, Bartosz Małkiewicz, Adam Gurwin, Wiktor Mateusz Krawczyk, Karolina Skonieczna-Żydecka, Artur Lemiński
Background: Neutrophil-to-lymphocyte ratio (NLR), a widely assessed biomarker in most common diseases, is typically evaluated before treatment initiation. However, data on NLR in the post-treatment setting is limited. Therefore, we assessed the NLR calculated after neoadjuvant chemotherapy (NAC) initiation in patients with bladder cancer (BC). We hypothesised that changes in blood cells after NAC could be a marker of tumour response and long-term survival. Materials and Methods: Our study included 214 patients who underwent NAC followed by radical cystectomy (RC) in two urological departments, wherein post-NAC NLR was used to categorize patients into the low (NLR ≤ 1...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38601437/hyperprogressive-disease-under-anti-pd-1-rechallenge-after-initial-response-to-anti-pd-1-treatment-for-non-small-cell-lung-cancer-a-case-report
#20
Shiting Xu, Takehito Shukuya, Shoko Shimamura, Takuo Hayashi, Yoshihiko Sato, Hitomi Shiozaki, Toshihiko Nishioki, Koichi Nishino, Motoyasu Kato, Aritoshi Hattori, Naoko Shimada, Kenji Suzuki, Shigehisa Kitano, Kazuhisa Takahashi
BACKGROUND: Hyperprogressive disease is an unexpected response pattern observed in immune checkpoint therapy and associated with poor prognosis. The rechallenge of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors can be a treatment option in non-small cell lung cancer (NSCLC) patients who once responded to them. Here, we reported the hyperprogressive phenomenon after PD-1/PD-L1 rechallenge in a patient with NSCLC. CASE DESCRIPTION: This case report described a patient with recurrent large cell lung cancer undergoing hyperprogressive disease with pleural and pericardial dissemination shortly after the pembrolizumab rechallenge, although he had a favorable response to the initial pembrolizumab treatment...
March 29, 2024: Translational Lung Cancer Research
keyword
keyword
68077
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.